| Literature DB >> 29146106 |
Zachary Aron1, Timothy J Opperman2.
Abstract
Resistance-nodulation-division (RND) superfamily efflux pumps play a major role in multidrug resistance (MDR) of Gram-negative pathogens by extruding diverse classes of antibiotics from the cell. There has been considerable interest in developing efflux pump inhibitors (EPIs) of RND pumps as adjunctive therapies. The primary challenge in EPI discovery has been the highly hydrophobic, poly-specific substrate binding site of the target. Recent findings have identified the hydrophobic trap, a narrow phenylalanine-lined groove in the substrate-binding site, as the "Achilles heel" of the RND efflux pumps. In this review, we will examine the hydrophobic trap as an EPI target and two chemically distinct series of EPIs that bind there.Entities:
Keywords: Adjunctive therapy; Efflux pump; Efflux pump inhibitor; Hydrophobic trap; RND superfamily
Mesh:
Substances:
Year: 2017 PMID: 29146106 PMCID: PMC5949246 DOI: 10.1016/j.resmic.2017.11.001
Source DB: PubMed Journal: Res Microbiol ISSN: 0923-2508 Impact factor: 3.992